Meanwhile, the weekly positivity rate has come down to 0.99 per cent while daily positivity rate stands at 0.74 per cent.
The US has already approved the fourth dose for immunocompromised people, such as those living with HIV or certain transplant recipients. Other countries that have approved the fourth shot include the UK, Chile.
Lifestyle changes do not only consist of diet and exercise but stepping outdoors for getting your mandatory dose of Vitamin D is also an important component of a healthy lifestyle, he added further while speaking on the importance of lifestyle in the prevention of diseases during Health4All Episode.
A universal vaccine which will protect people against all future variants of the lethal coronavirus! How does that sound? Well, a team of Indian scientists claims to have designed a peptide vaccine which can be effective against all the variants of SARS-COV-2.
As per the government CoWIN portal, India has administered over 170 crore of vaccine doses so far that includes over 95 crore of first doses, over 73 crore as second shots and over 1.45 crore precaution doses.
The trials would evaluate the safety, tolerability and immunogenicity of the vaccine candidate, according to a joint statement by the companies on Tuesday. The study would involve up to 1,420 participants.
In the vaccination drive, the country has achieved several milestones, which have no precedent in the world, including administering over 100 crore doses in less than nine months, administering 2.51 crore doses in a single day and several times administering one crore doses in a day, it said.
The World Health Organisation (WHO) has said that current Covid-19 vaccines may need to be updated if they are to provide continued protection against emerging variants, including Omicron.
"Great Going, my Young Friends. Over 2 crore youngsters between the 15-18 age group have received their first dose of COVID-19 vaccine in less than a week of vaccination drive for children," Mandaviya tweeted.
According to a source, Bharat Biotech aims to conduct clinical trials on 5,000 healthy subjects: half or 2,500 individuals who have received Covishield and another 2,500 who have been administered Covaxin.
Only Covaxin vaccine has been given to those who are in the 15-18 age group.
Mishra said that a person is eligible to get the dose if the gap between the second dose of Covid vaccine and the registration date for the booster is more than 9 months (39 weeks).
At present, the State has 7.05 lakh healthcare and frontline workers and around 10.47 lakh people above 60 years with co-morbidities, said the top health official.
Over 25 lakh eligible beneficiaries between 15-18 years age group in Odisha will start receiving doses from January 3.
India charts a separate way. Addressing the nation on Saturday, PM Narendra Modi announced that children in the 15-18 years age group will now get COVID-19 vaccines starting 3rd January 2022. The government has also decided that precaution dose of vaccine will be started for frontline workers and healthcare workers and elderly with co-morbid conditions.
Copyright © 2024 - Odisha Television Limited All Rights Reserved.